Back

A cellular model of Brugada Syndrome with CACNB2 mutation of human-induced pluripotent stem cell-derived cardiomyocytes

27 August 2018 (17:05 - 17:15)
Organised by:
Congress Presentation Part of: Arrhythmogenic channelopathies Ion Channel Disorders ESC Premium Access ESC Congress 2018

About the speaker

Photo
Mrs Theresa Schimanski

(Germany)

5 More presentations in this session

Presentation thumbnail
Population based prevalence of Brugada syndrome in a young male population in southeast asia
Doctor X. Shen (Singapore, SG)
Abstract Slides Video
Presentation thumbnail
Systematic re-evaluation of ion channel mutations associated with Brugada syndrome
Doctor N. Denham (Liverpool, GB)
Abstract Slides Video
Presentation thumbnail
10 years of follow-up in carriers of a RyR2 pathogenic mutation with uncertain penetrance. What have we learned?
Doctor A. Cardenes Leon (Las Palmas de Gran Canaria, ES)
Abstract Slides Video
Presentation thumbnail
Novel SCN5A mutation associated with multifocal ectopic purkinje-related premature contractions
Mr M. Holl (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
The importance of variant re-evaluation in massive parallel sequencing: results from hypertrophic cardiomyopathy genetic testing as an example
Doctor P. Norambuena (Prague, CZ)
Abstract Slides Video

Access the full session

Session thumbnail
Arrhythmogenic channelopathies

The Event

Event poster

ESC Congress 2018

27 August 2018 17:05 CET
You may be interested in
thumbnail
Congress Presentation
Ca2+ handling in induced-pluripotent cardiomyocytes from female CPVT patient, and comparison to male.
23 April 2021
thumbnail
Congress Session
EHRA Consensus Paper on Pharmacological Provocation Testing
1 April 2025
thumbnail
Congress Session
Risk stratification
30 March 2025
thumbnail
Congress Presentation
The role of MAPRE2 and microtubules in Brugada syndrome pathogenesis
25 August 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources